Investigating the stereochemistry of binding to HIV-1 protease with inhibitors containing isomers of 4-amino-3-hydroxy-5-phenylpentanoic acid

Biochem Biophys Res Commun. 1991 Oct 15;180(1):187-90. doi: 10.1016/s0006-291x(05)81274-4.

Abstract

A series of inhibitors containing all possible isomers of 4-amino-3-hydroxy-5-phenylpentanoic acid was synthesized and tested for inhibition of HIV-1 protease. Incorporation of the (3S,4S) isomer of the t-butyloxycarbonyl protected amino acid into the sequence Glu-Phe resulted in a potent inhibitor of HIV-1 protease (Ki = 63 nM). This inhibitor is at least 47-times more potent than the inhibitors containing other isomers of 4-amino-3-hydroxy-5-phenylpentanoic acid, indicating that the (3S,4S) isomer is the preferred isomer for binding to HIV-1 protease.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Enzyme Inhibitors
  • HIV Protease / chemistry*
  • Kinetics
  • Molecular Sequence Data
  • Stereoisomerism
  • Substrate Specificity

Substances

  • Enzyme Inhibitors
  • HIV Protease